Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CalciMedica Inc CALC

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.


NDAQ:CALC - Post by User

User Avatar Image
(1)
•••
  • lowlygeoX
Post by lowlygeoon Nov 14, 2021 2:12pm
247 Views
Post# 34124906

What do we have here

What do we have hereSo another press release showing the same cross section. Dragging in data from Beijing to "correlate" with data from London. Based on their release , you have two ( we don't know true widths) (very) narrow high grade, veins. They will be most definately less than 1 metre in true width. Why don't they show more than one section and show us a plan of the drilling. So you need to ask yourself , can you every mine this stuff. Well we don't know. Perhaps if they demonstrated some along strike potential and shown some volume to this perhaps.
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities